Evidence-Based Product Development and Differentiation
First written in FY2025. 7 of 10 entries say "Advanced", first in FY2025. Latest entry: 2026-05-14.
115 other companies' latest entry also says "Advanced".
- FY2026-H1RestatedAnnual report
「Research and development expenses for the interim accounting period amounted to ¥67.619 million. There were no material changes in the status of the Company's research and development activities during the interim accounting period.」
The Company continues its research and development activities and states that there have been no material changes in their status. - 2026-04-01AdvancedOther Disclosures
「In in-house testing, the company confirmed a tendency for humidity within the bedding environment to remain lower than with conventional polyester summer bedding.」
The company presented in-house test results concerning humidity within the bedding environment and perceived fatigue during sleep for the new products. - FY2025AdvancedAnnual report
「In addition, we conducted 14 evidence studies, including internal validation, and launched 7 research and development projects.」
The Company reported the number of evidence studies and research and development projects conducted. - FY2025First statedAnnual report
「We have obtained data supporting the efficacy and benefits of our products through collaboration with universities, hospitals and other institutions.」
The Company uses data obtained through research and development for medical device notifications and product differentiation.